Globant's (GLOB) organic growth is expected to improve in 2025 but foreign exchange remains a challenge, UBS said in a note sent Monday.
Contribution to overall growth from mergers and acquisitions will likely decline, the firm added in its Q4 earnings preview for the software development company.
Globant's Q4 2024 results are expected to show a decline in revenue from certain large-scale projects, which will be partially mitigated by higher US revenue, it said. UBS is forecasting revenue growth of 10.5% year-over-year for the quarter and 15.2% growth for full-year 2024, suggesting that topline numbers for the quarter and the year will be at the bottom of guidance ranges.
The investment firm trimmed its price target for the stock to $217 from $222, while maintaining a neutral rating.
"While FX translations should limit USD-growth, we note that GLOB's long exposure to USD helps it to navigate in a volatile FX scenario," UBS said.
Price: 212.91, Change: -0.41, Percent Change: -0.19
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。